Myrtelle shared clinical trial updates and future directions for Oligodendrocyte targeting AAVs at the 27th Annual Meeting of the ASGCT.
Recognizing the challenges of drug development, the US FDA has established several special designations and…
Recognizing the challenges of drug development, the US FDA has established several special designations and…